BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210415T100000
DTEND;TZID=America/New_York:20210415T110000
DTSTAMP:20260406T050305
CREATED:20210409T185358Z
LAST-MODIFIED:20210409T185358Z
UID:13679-1618480800-1618484400@www.masslifesciences.com
SUMMARY:Neurology Clinical Trials Are Failing. How Can We Fix Them?
DESCRIPTION:One billion people worldwide suffer from neurological related disorders with limited therapy options. Over 2000 neurological clinical trials start each year in the US alone. Yet\, it is estimated that only 5.9% of Phase I neurology drugs are likely to get FDA approval. \nResearch innovation such as new biomarkers or advanced algorithms often do not get translated into clinical practice\, slowing progress. Adding to that\, the scale\, inefficiency and subjectivity of neurological clinical trials makes them inherently difficult. Neuroimaging analysis is key to developing new therapies for brain disease but it’s difficult to do. \nJoin us for a discussion and audience Q&A hosted by QMENTA CEO\, Vesna Prčkovska. Hear from our esteemed panel of experts who work across the life sciences research\, development and care spectrum how clinical research leaders can take key steps now to transform the way they conduct neuroimaging based clinical trials to position them for success. Seats are limited so register now.
URL:https://www.masslifesciences.com/event/neurology-clinical-trials-are-failing-how-can-we-fix-them/
LOCATION:Zoom
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210413T083000
DTEND;TZID=America/New_York:20210413T094500
DTSTAMP:20260406T050305
CREATED:20210318T140830Z
LAST-MODIFIED:20210318T140852Z
UID:13565-1618302600-1618307100@www.masslifesciences.com
SUMMARY:Life Sciences & Sustainability: Exploring Opportunities with Alexandria Real Estate
DESCRIPTION:Scientific research is one of the greatest drivers of the Boston economy – and\, one of the greatest drivers of greenhouse gas emissions. How will laboratory buildings achieve net zero emissions without putting the squeeze on this critical economic engine? Alexandria Real Estate is often considered to be the gold standard for life science development. They are also setting the gold standard for ultra-low emissions laboratory buildings. How are they achieving this impressive goal? \nJoin the BSA\, Rick Malmstrom of Alexandria Real Estate and Jacob Knowles of BR+A for a Client Conversations exploration of their integrated design work that will achieve this goal\, focusing on the under construction\, 500\,000 GSF core-shell lab in Kendall Square that will approach fossil fuel free for space heating.
URL:https://www.masslifesciences.com/event/life-sciences-sustainability-exploring-opportunities-with-alexandria-real-estate/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210412T093000
DTEND;TZID=America/New_York:20210416T110000
DTSTAMP:20260406T050305
CREATED:20210409T185921Z
LAST-MODIFIED:20210409T185935Z
UID:13632-1618219800-1618570800@www.masslifesciences.com
SUMMARY:MassBioEd Career Exploration Week
DESCRIPTION:MassBioEd will be holding a series of 1-hour virtual Career Exploration events with five (5) different life sciences companies or academic institutions during the week of April 12th-16th. Each day\, students will have the chance to hear from professionals working in the industry and experience a virtual lab tour or lab demonstration. Participating companies include: Northeastern University\, MilliporeSigma\, Valo Health\, Arranta Bio\, and Thermo Fisher Scientific. Students\, educators and parents are all welcome to register! \nClick the registration link for more information regarding the event schedule. \nFor questions\, contact Kretsy Mondesir at Kretsy.mondesir@massbioed.org
URL:https://www.masslifesciences.com/event/massbioed-career-exploration-week/2021-04-12/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210409T140000
DTEND;TZID=America/New_York:20210409T160000
DTSTAMP:20260406T050305
CREATED:20210318T141207Z
LAST-MODIFIED:20210318T141207Z
UID:13566-1617976800-1617984000@www.masslifesciences.com
SUMMARY:Virtual Career Fair -Life Science Consortium North Shore
DESCRIPTION:The Life Science Consortium of the North Shore has convened a variety of life science companies ranging in size and technical disciplines\, all with facilities North of Boston. Students and alumnae of the Consortium schools will have the chance to learn about the participating companies from brief presentations on Zoom. Then students can select virtual networking breakout rooms to speak with employers that interest them. In these breakout rooms\, employers can connect with students regarding internship and job opportunities\, and answer questions about their company. This is a free event for both employers and students.
URL:https://www.masslifesciences.com/event/virtual-career-fair-life-science-consortium-north-shore/
LOCATION:Online\, online
ORGANIZER;CN="Life Science Consortium of the North Shore":MAILTO:lynn.sutherland@nsiv.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210408T173000
DTEND;TZID=America/New_York:20210408T190000
DTSTAMP:20260406T050305
CREATED:20210222T124313Z
LAST-MODIFIED:20210222T124313Z
UID:13388-1617903000-1617908400@www.masslifesciences.com
SUMMARY:Science Club for Girls - Virtual Catalyst Awards 2021
DESCRIPTION:Virtual Nonprofit Event\n100% of the proceeds from this event will be donated to Science Club for Girls \nJoin us for an inspiring evening where you’ll hear stories from our community\, see our Science Clubs ‘in action’\, and meet some remarkable women who are paving the way for a more diverse\, inclusive world of STEM. \n5:30 – 6:00 P.M. – Networking\n6:00 – 7:00 P.M. – Main event \nThis year\, we are excited to be honoring Beth Chandler\, CEO of YW Boston\, and Rana el Kaliouby\, Ph.D.\, CEO and Co-Founder of Affectiva as our Catalyst Awardees!
URL:https://www.masslifesciences.com/event/science-club-for-girls-virtual-catalyst-awards-2021/
LOCATION:Online\, online
ORGANIZER;CN="Science Club for Girls":MAILTO:scfg@scienceclubforgirls.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210406T120000
DTEND;TZID=America/New_York:20210406T124500
DTSTAMP:20260406T050305
CREATED:20210222T124407Z
LAST-MODIFIED:20210222T124407Z
UID:13387-1617710400-1617713100@www.masslifesciences.com
SUMMARY:Biopharma R&D During COVID-19: One Year Later
DESCRIPTION:The SARS-CoV-2 pandemic brought new challenges and opportunities to biotech and pharmaceutical companies. Several new vaccines and therapies have already been brought to patients. Companies initiated efforts to catalyze collaborative research\, new ways of working and social justice. One year into the pandemic\, we will examine the initial lessons for biopharma R&D – what worked\, what didn’t\, and how can the industry sustain momentum on emerging priorities for the future? Join Harvard Medical School Executive Education for a discussion with three of the industry’s top leaders. \nSpeakers: \nJay Bradner\, MD\nPresident\, Novartis Institutes for BioMedical Research (NIBR)\nExecutive Committee Member\, Novartis \nAndrew Plump\, MD\, PhD\nPresident\, Research & Development\, Takeda Pharmaceuticals \nMichelle McMurry-Heath\, MD\, PhD\nPresident & CEO\, Biotechnology Innovation Organization (BIO)
URL:https://www.masslifesciences.com/event/biopharma-rd-during-covid-19-one-year-later/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210405T150000
DTEND;TZID=America/New_York:20210409T173000
DTSTAMP:20260406T050305
CREATED:20210203T221220Z
LAST-MODIFIED:20210203T221220Z
UID:13188-1617634800-1617989400@www.masslifesciences.com
SUMMARY:Business of Biotech 201: From Molecule to Market\, R&D and Regulatory Considerations
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nThis MassBioEd online course builds on the business overview of “The Business of Biotech 101” course. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry\, this course delivers an outline of Clinical\, Regulatory\, and Quality considerations and practices. Students will be provided foundational information about the BioPharma industry and regulations via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share and phases of development. \nGuest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will review Research and Development processes and considerations from pre-clinical through market approval. \nSchedule \nMonday\, April 5th\, 2021 03:00 PM – 05:30 PM EST\nWednesday\, April 7th\, 2021 03:00 PM – 05:30 PM EST\nFriday\, April 9th\, 2021 03:00 PM – 05:30 PM EST\nAgenda \nSession 1:\nThe History of Regulations\nIndustry Overview\nResearch & Development: An Overview of R&D \nSession 2:\nRoles in Clinical Trials\nMarketing Considerations \nSession 3:\nCompliance via Regulatory & Quality Processes
URL:https://www.masslifesciences.com/event/business-of-biotech-201-from-molecule-to-market-rd-and-regulatory-considerations/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210405T000000
DTEND;TZID=America/New_York:20210430T000000
DTSTAMP:20260406T050305
CREATED:20210127T191328Z
LAST-MODIFIED:20210127T191328Z
UID:13146-1617580800-1619740800@www.masslifesciences.com
SUMMARY:Driving Health Care Strategy in the COVID Era: Business Insights from Inside the Ecosystem
DESCRIPTION:A Harvard Medical School executive education program designed to provide a 360 degree immersion into the forces shaping health care. \nThe coronavirus pandemic has revealed many vulnerabilities within the global health care ecosystem. These challenges present opportunities for companies and health systems to create new value for health care. What strategies should you be developing for the COVID era? Whether you are a seasoned health care executive\, or a business leader looking to move into health care\, this program will prepare you to launch or advance initiatives that create new value in health care. \nHealth care is being transformed by several converging forces including the accelerating growth of machine learning\, genomics and precision medicine\, digital technologies\, changes in reimbursement and a renewed focus on the patient at the center of care. These forces will shape the challenges and opportunities for industry stakeholders across all health care sectors. In order for innovations to succeed and meet important unmet needs of patients\, providers or payers\, business and science leaders need an in-depth understanding of the current health care ecosystem.
URL:https://www.masslifesciences.com/event/driving-health-care-strategy-in-the-covid-era-business-insights-from-inside-the-ecosystem/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210331T120000
DTEND;TZID=America/New_York:20210331T133000
DTSTAMP:20260406T050305
CREATED:20210318T140429Z
LAST-MODIFIED:20210318T140429Z
UID:13570-1617192000-1617197400@www.masslifesciences.com
SUMMARY:How 3D Printing is Reshaping the Future of Health Tech
DESCRIPTION:3D printing has the potential to disrupt how innovators create and providers deliver healthcare solutions\, changing and impacting lives of patients. Join Johnson & Johnson Innovation – JLABS on 3/31 to hear from experts in the field on where they think the future of 3D printing is headed\, advancements that are on the horizon and the future of these printed healthcare solutions.
URL:https://www.masslifesciences.com/event/how-3d-printing-is-reshaping-the-future-of-health-tech/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210330T093000
DTEND;TZID=America/New_York:20210330T103000
DTSTAMP:20260406T050305
CREATED:20210318T140535Z
LAST-MODIFIED:20210318T140535Z
UID:13567-1617096600-1617100200@www.masslifesciences.com
SUMMARY:Tufts Research Forums 2021: Successes and Challenges of the COVID-19 Vaccine Rollout in the Global Context
DESCRIPTION:Building on the themes that emerged from the Tufts 2020 COVID-19 Research Symposium: Research. Policy. Solutions\, the Office for the Vice Provost for Research will host a series of Research Forums this year. Curated by the COVID-19 Research Steering Committee\, these forums highlight Tufts’ unique niche in the research landscape and its ability to address issues in research equity and health to positively impact our local and global communities. The first topic of the series is Successes and Challenges of the COVID-19 Vaccine Rollout in the Global Context. \nThis event will explore critical issues related to the development and implementation of the COVID-19 vaccination program across the globe. After brief presentations\, the conversation will focus on how to ensure equitable access to the COVID-19 vaccine. \nThe expert panel will include Dr. Salim Abdool Karim\, FRS\, Director of the Centre for the AIDS Program of Research in South Africa\, and Dr. Ramanan Laxminaryanan\, Founder and Director of the Center for Disease Dynamics\, Economics & Policy\, presenting on India. The session will be moderated by Dr. Simone Wildes\, a Tufts Medical Center affiliated Infectious Disease Physician based out of South Shore Hospital and a member of the Massachusetts COVID-19 Vaccine Advisory Group. \nSponsored by the Office for the Vice Provost for Research. \nThis event is open to the public and registration is required. \nIf you have any questions\, please contact covid19research@tufts.edu.
URL:https://www.masslifesciences.com/event/tufts-research-forums-2021-successes-and-challenges-of-the-covid-19-vaccine-rollout-in-the-global-context/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210329T120000
DTEND;TZID=America/New_York:20210329T124500
DTSTAMP:20260406T050305
CREATED:20210222T124519Z
LAST-MODIFIED:20210222T124519Z
UID:13386-1617019200-1617021900@www.masslifesciences.com
SUMMARY:Health Care Leadership During COVID-19
DESCRIPTION:The COVID-19 pandemic has upended health care delivery and economics. This Harvard Medical School Executive Education webinar will provide the behind-the-scenes perspective of a senior hospital leader in a time of crisis. Dr. Kimball will discuss how she and her leadership team adapted to the immediate crisis as well as its prolonged evolution\, from establishing a command structure to discovering hidden talents on their team. The session will explore leadership lessons and her insights for the path forward.
URL:https://www.masslifesciences.com/event/health-care-leadership-during-covid-19/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210329T090000
DTEND;TZID=America/Los_Angeles:20210401T170000
DTSTAMP:20260406T050305
CREATED:20201215T182328Z
LAST-MODIFIED:20201215T182328Z
UID:12877-1617008400-1617296400@www.masslifesciences.com
SUMMARY:Festival of Biologics Usa
DESCRIPTION:The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry. With three events in one across Antibodies\, Immunotherapy and Biosimilars\, the Festival encourages conversation across the entire industry so you can inspire change\, champion innovation\, and address complex challenges that the industry is facing. \nOur mission is to bring together senior biologics professionals across the antibody\, immunotherapy\, and biosimilar value chains to showcase their research\, collaborate on challenges\, forge new connections and ultimately advance the industry to improve patient health.
URL:https://www.masslifesciences.com/event/festival-of-biologics-usa/
LOCATION:Online\, online
ORGANIZER;CN="Terrapinn":MAILTO:bree.vaughn@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210325T120000
DTEND;TZID=America/New_York:20210325T133000
DTSTAMP:20260406T050305
CREATED:20210304T023545Z
LAST-MODIFIED:20210304T023545Z
UID:13475-1616673600-1616679000@www.masslifesciences.com
SUMMARY:WIB-Greater Boston: Sixth Annual Lobster Pot Pitch Event
DESCRIPTION:What better way to honor Women’s History Month than to celebrate powerful women in the life sciences? Come to WIB-Greater Boston’s famous 6th Annual Lobster Pot. \nAs the name suggests\, this event will be in the “shark tank style\,” with each fundraising executive pitching to investors and the audience. The investors will provide feedback on the pitch and comment on the ideas presented. Join us on March 25\, 2021\, to learn how to pitch to investors more effectively\, and to check out some exciting NewCos in the life sciences space. \nSo whether you are starting your own company\, raising money\, or just want to celebrate powerful women\, this is one event that you can’t afford to miss. \nDisclaimer: This event may be recorded. There is a possibility your image and/or voice may be a part of that recording. If you are uncomfortable\, please be sure to turn off your webcam. \nProgram \n12:00 p.m. – 12:05 p.m. Welcome & Event Overview\n12:05 p.m. – 12:10 p.m. Panelist Introductions\n12:10 p.m. – 1:30 p.m. Company Pitches & Investor Feedback \n15 min each (6 min. pitches\, 6 min. feedback\, 1 min. transition\, 2 min. buffer) \n12:10 p.m. – 12:25 p.m. Company 1\n12:25 p.m. – 12:40 p.m. Company 2\n12:40 p.m. – 12:55 p.m. Company 3\n12:55 p.m. – 1:10 p.m. Company 3\n1:10 p.m. – 1:25 p.m. Panel Discussion\, Q&A\n1:25 p.m. – 1:30 p.m. Thanks and Closing Remarks \nSpeakers \nModerator \nMarian Nakada\, Ph.D.\, Vice President\, Venture Investments\, J&J Innovation JJDC \nVC panelists \nLaura Brass\, Ph.D.\, MBA\, Partner\, Novartis Venture Fund\nRuta Laukien\, Graybella Capital\nClaire Leurent\, Johnson & Johnson Innovation \nNewCo Pitches \nErika Smith\, CEO\, ReNetX Bio\, Inc\nElizabeth Gazda\, CEO\, Embrlabs\nMaria Luisa Pineda\, CEO & Co-Founder\, Envisagenics\nNatalie Artzi\, Ph.D. Co-Founder\, BioDevek \nPricing Information \nMembers: Free\nNon-members*: $10\nOptional Donation: $5
URL:https://www.masslifesciences.com/event/wib-greater-boston-sixth-annual-lobster-pot-pitch-event/
LOCATION:Online\, online
ORGANIZER;CN="Women in Bio":MAILTO:info@womeninbio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T170000
DTEND;TZID=America/New_York:20210324T233000
DTSTAMP:20260406T050305
CREATED:20210304T023414Z
LAST-MODIFIED:20210304T023420Z
UID:13485-1616605200-1616628600@www.masslifesciences.com
SUMMARY:2021 M2D2 $200K Challenge Pitch-Off & Awards Celebration
DESCRIPTION:Calling all Investors\, Medical Device Innovators\, Biotech Entrepreneurs\, Academics\, Students\, and Life Sciences Industry Professionals:\nJoin the worldwide life sciences community online as the $200K Challenge finalists selected through a competitive process pitch their innovations virtually to our panel of judges. At stake: a share of a $200\,000 purse of sponsor-provided\, in-kind resources that can help take an innovation to the next level—or even to market! \n(Examples of in-kind resources include lab space\, equipment\, and legal/regulatory guidance) \nWe’ve seen past winners advance to larger funding rounds\, commence clinical studies\, and enter strategic partnerships with global life sciences companies. The $200K Challenge is the place to see what’s up-and-coming in life sciences innovation. \nTICKETS ARE FREE—CHOOSE ONE OR BOTH EVENTS:\nFinalist Pitch-Off — Wednesday\, March 24th @ 5pm ET\nOur 15 Finalists will each have four minutes to make their cases to our panel. \nKEYNOTE SPEAKER: Kenn Turner\, President & CEO of Mass Life Sciences \nAwards Celebration — Wednesday\, April 7th @ 5pm ET\nJoin us for the announcement of the $200K Challenge winners! \nTHANK YOU TO OUR 2021 SPONSORS!
URL:https://www.masslifesciences.com/event/2021-m2d2-200k-challenge-pitch-off-awards-celebration/2021-03-24/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T160000
DTEND;TZID=America/New_York:20210324T190000
DTSTAMP:20260406T050305
CREATED:20210310T205507Z
LAST-MODIFIED:20210310T205507Z
UID:13517-1616601600-1616612400@www.masslifesciences.com
SUMMARY:BioXchange Sponsored by Pinnacle Technology Partners (PTP)
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. This month’s event will be sponsored by Pinnacle Technology Partners (PTP). \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the end time posted as the room will stay open as long as people are actively engaged within the chat room.\n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform. \nMore about this month’s sponsor: \nPTP architects\, implements and optimizes AWS technology solutions that enable life sciences organizations to develop faster\, lower IT costs\, and scale their operations. The AWS platform is trusted by the largest enterprises and the hottest startups alike to power a wide variety of workloads\, including web and mobile applications\, data analytics\, application development\, data processing\, warehousing\, storage\, archive and much more. \nWe are located in the Boston area\, the hub of some of the most innovative companies and research institutions in the world in the life sciences\, biotech\, biopharma and healthcare spaces. We work with companies from start-up to seed funding\, from public to pre-IPO\, to help them meet security compliance requirements (HIPAA\, GxP\, etc.)\, reduce infrastructure costs\, improve operational efficiencies\, and ultimately innovate faster. Working alongside their IT teams\, or directly with their scientists\, we design and deploy flexible infrastructure solutions on AWS.
URL:https://www.masslifesciences.com/event/bioxchange-sponsored-by-pinnacle-technology-partners-ptp/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T140000
DTEND;TZID=America/New_York:20210324T150000
DTSTAMP:20260406T050305
CREATED:20210318T140631Z
LAST-MODIFIED:20210318T140631Z
UID:13569-1616594400-1616598000@www.masslifesciences.com
SUMMARY:FDA and Emergency Use Authorization (EUA): Latest Updates for Startups.
DESCRIPTION:Alira Health and Mansfield Bio-Incubator present\, a U.S. Regulatory Update with Alira Health’s Mary McNamara-Cullinane\, Senior VP Regulatory \nAbout this Event \nJoin Alira Health’s Senior Vice President\, Regulatory Affairs\, Mary McNamara-Cullinane for a timely\, interactive event\, where Mary will give an update on the FDA\, including a walkthrough of the EUA process\, and best practices for submission development based on the latest FDA guidance. \nWho should attend: Entrepreneurs in biotech\, pharmaceuticals\, medical devices\, and other healthcare-related fields planning to approach FDA within the next year. Investors in these fields looking for guidance. \nThe presentation will be followed by a question-and-answer session.
URL:https://www.masslifesciences.com/event/fda-and-emergency-use-authorization-eua-latest-updates-for-startups-2/
LOCATION:Online\, online
ORGANIZER;CN="Mansfield Bio-Incubator":MAILTO:info@bioinc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T140000
DTEND;TZID=America/New_York:20210324T150000
DTSTAMP:20260406T050305
CREATED:20210310T205745Z
LAST-MODIFIED:20210310T205804Z
UID:13512-1616594400-1616598000@www.masslifesciences.com
SUMMARY:FDA and Emergency Use Authorization (EUA): Latest Updates for Startups.
DESCRIPTION:Alira Health and Mansfield Bio-Incubator present\, a U.S. Regulatory Update with Alira Health’s Mary McNamara-Cullinane\, Senior VP Regulatory \nAbout this Event \nJoin Alira Health’s Senior Vice President\, Regulatory Affairs\, Mary McNamara-Cullinane for a timely\, interactive event\, where Mary will give an update on the FDA\, including a walkthrough of the EUA process\, and best practices for submission development based on the latest FDA guidance. \nWho should attend: Entrepreneurs in biotech\, pharmaceuticals\, medical devices\, and other healthcare-related fields planning to approach FDA within the next year. Investors in these fields looking for guidance. \nThe presentation will be followed by a question-and-answer session.
URL:https://www.masslifesciences.com/event/fda-and-emergency-use-authorization-eua-latest-updates-for-startups/
LOCATION:Online\, online
ORGANIZER;CN="Mansfield Bio-Incubator":MAILTO:info@bioinc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210322T123000
DTEND;TZID=America/New_York:20210326T150000
DTSTAMP:20260406T050305
CREATED:20210203T224814Z
LAST-MODIFIED:20210203T224814Z
UID:13187-1616416200-1616770800@www.masslifesciences.com
SUMMARY:Business of Biotech 101
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nBusiness of Biotech 101 explores the business considerations that drive company strategies. Participants are provided with an overview of how the industry works\, why it works the way it does\, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side\, this course delivers a sound\, basic understanding of the “business of biotech”. Students will be provided foundational information about the BioPharma industry and regulation via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share\, phases of development\, patient population\, and safety profile. Guest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will embark upon a high-level overview of Research and Development\, including pre-clinical through market approval. \nSchedule \nMonday\, March 22nd\, 2021 12:30 PM – 3:00 PM EST\nWednesday\, March 24th\, 2021 12:30 PM – 3:00 PM EST\nFriday\, March 26th\, 2021 12:30 PM – 3:00 PM EST\nAgenda \nSession 1:\nOrigins of the Biotech Industry: a Brief History\nAddressing Unmet Medical Need\nBiotechnology techniques used for therapeutics development\nBiotech Entrepreneurship\nBusiness Models of the Sector and Industries within \nSession 2:\nPreclinical\nClinical Development\nCreating Barriers to Entry: Market Exclusivity \nSession 3\nPatents\nEarly Stage Financing
URL:https://www.masslifesciences.com/event/business-of-biotech-101-2/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210320T183000
DTEND;TZID=America/New_York:20210320T203000
DTSTAMP:20260406T050305
CREATED:20210222T123213Z
LAST-MODIFIED:20210222T123513Z
UID:13390-1616265000-1616272200@www.masslifesciences.com
SUMMARY:2021 INSPIRE STEM Gala presented by NSBE Boston
DESCRIPTION:A virtual fundraising event to benefit STEM programs impacting Black Students. Stay IN for STEM with us on March 20. \n\n\n\n\nNSBE Boston Professionals invites you to our Annual INSPIRE STEM Scholarship Fundraiser & Awards gala on March 20th\, 2021. This year’s virtual event will benefit NSBE Boston’s year-round Youth STEM (science\, technology\, engineering & math) initiatives and also honor the accomplishments of Black leaders who are inspiring a generation of future black innovators. \nLive Entertainment | Auction | Trivia | Scholarship \nStay in for STEM! (we will reconvene again very soon!) \nDate: Saturday\, March 20th\, 2021 | Venue: Virtual Event \nDress code: No Rules! (this year we are having fun) \nBecome a sponsor – View sponsorship opportunities \nGala Honorees\nKenn Turner\, President & CEO\, Massachusetts Life Sciences Center \nEnna Jimenez\, Sr. Dir. & Head of Quality Assurance at IDEEMA \nFrederick M. Lowery\, Sr. VP & President\, Laboratory Products at ThermoFisher \nDr. Sara Suliman\, Immunologist & Research Scientist at Brigham and Women’s Hospital/Harvard Medical School \nH.G. Chissell\, Founder & CEO of Advanced Energy Group \nScholarship Award winners (TBA)\nThe 2021 NSBE Boston STEM Ambassador scholarships will be presented during this event. The STEM Ambassadors Scholarship program aims to support students who have shown academic excellence and are also committed to amplifying NSBE’s “Be 1 of 10\,000 Black Engineers” national initiative of increasing interest in STEM. \n– Apply for the 2021 NSBE Boston scholarships \nClick here to Support our STEM Initiatives.\nThis program is organized by NSBE Boston Professionals with the generous support of our members\, corporate partners and community of givers. Our vision is to continue to expand opportunities for Black students and professionals\, and also increase access to STEM resources in Boston’s under-served communities.
URL:https://www.masslifesciences.com/event/2021-inspire-stem-gala-presented-by-nsbe-boston/
LOCATION:Online\, online
ORGANIZER;CN="National Society of Black Engineers":MAILTO:membership@nsbeboston.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210319T180000
DTEND;TZID=America/New_York:20210319T193000
DTSTAMP:20260406T050305
CREATED:20210308T151414Z
LAST-MODIFIED:20210308T151414Z
UID:13518-1616176800-1616182200@www.masslifesciences.com
SUMMARY:Tips to Secure internships & scholarships in 2021
DESCRIPTION:STEAMid simplifies access to academic resources (internships\, scholarships & fellowships) nationwide. We primarily serve high school\, college\, and graduate students from underrepresented backgrounds to promote entry and success in all STEAM disciplines. \nThrough the upcoming webinar\, we aim to:\n(1) Expose students\, parents\, and educators to academic resources nationwide.\n(2) Cover the nuts & bolts of a strong application to improve a student’s odds of success.
URL:https://www.masslifesciences.com/event/tips-to-secure-internships-scholarships-in-2021/
LOCATION:Virtual Event
ORGANIZER;CN="STEAMid":MAILTO:roo@mysteamid.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210315T090000
DTEND;TZID=America/New_York:20210319T113000
DTSTAMP:20260406T050305
CREATED:20210203T225025Z
LAST-MODIFIED:20210203T225025Z
UID:13185-1615798800-1616153400@www.masslifesciences.com
SUMMARY:Science of Biotech 101
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nScience of Biotech 101 is designed for the non-scientist as a survey of the basic biological processes that are foundational to the biopharma and life sciences industry. You will apply your new understanding of basic cell and molecular biology to the work of most life sciences companies that research and develop therapies and products that improve lives\, enhance agriculture\, and decrease the dependence on fossil fuels. \nSchedule \nMonday\, March 15th\, 2021 9:00 – 11:30 AM\nWednesday\, March 17th\, 2021 9:00-11:30 AM\nFriday\, March 19th\, 2021 9:00-11:30 AM\nAgenda \nSession 1:\nIntroductions\nIndustry Overview\nThe Raw Materials of Biotechnology: Protein and Cells\nIndustry Applications: The Raw Materials of Biotechnology: DNA \nSession 2:\nMolecular Biology: From DNA to Protein\nGenetics: Chromosomes\, Genes and Genomes\nIndustry Applications \nSession 3:\nGenetic Engineering\nThe Immune System\nIndustry Applications: Mitigating Disease
URL:https://www.masslifesciences.com/event/science-of-biotech-101/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210312T110000
DTEND;TZID=America/New_York:20210312T130000
DTSTAMP:20260406T050305
CREATED:20210304T023143Z
LAST-MODIFIED:20210304T023143Z
UID:13488-1615546800-1615554000@www.masslifesciences.com
SUMMARY:BARDA Vaccines against Anti-Microbial Resistance (AMR) Workshop
DESCRIPTION:Are you working to develop a vaccine against E. coli (urinary)\, Klebsiella pneumoniae\, Pseudomonas aeruginosa\, or Staphylococcus aureus? \nCompanies and others interested in working with BARDA on AMR are encouraged to attend. The event is open to the public\, but space is limited. Be sure to register by March 5\, 2021. Please\, no more than four people from one organization. \nOne-on-One Meetings: Are you a product developer working on a vaccine against one of the four targeted pathogens (listed on the website link below)? Be sure to request a private meeting when you register for the workshop.
URL:https://www.masslifesciences.com/event/barda-vaccines-against-anti-microbial-resistance-amr-workshop/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210310T100000
DTEND;TZID=America/New_York:20210310T113000
DTSTAMP:20260406T050305
CREATED:20201124T161339Z
LAST-MODIFIED:20201124T161555Z
UID:12769-1615370400-1615375800@www.masslifesciences.com
SUMMARY:Panel 4: New Pathways for a Data Science Workforce
DESCRIPTION:Panel 4 Guiding Question: ​\nHow might EDC’s expertise in developing and implementing ​HS and CC data science initiatives form a key element of ​a sustained\, multi-year effort to grow\, in collaboration with others\, the size and diversity of the state’s future data science workforce?​ \nPanelist\nModerator\, Sarita Pillai\, EDC\nMichael Harris\, Bunker Hill Community College\nRandy Kochevar\, EDC\nRebecca Lewis\, EDC\nJoyce Malyn-Smith\, EDC \nExpanding Access to Data Science Careers\nEach discussion in the panel series will address a key component critical to the development of a strategic plan to extend and expand the early-stage Data Science pipeline: \n\nTo understand the need for a career pathway that begins with high school and community college students.\nTo review existing policies in Massachusetts that support efforts to prepare more students for Data Science careers\, and discuss what additional policy support might be needed.\nTo learn from programs that broaden participation in other disciplines and apply those best practices in developing outreach and support programs for a more diverse community of students.\nTo discover current initiatives for high school and community college students and discuss how they may form the basis of the early-stage Data Science pipeline.
URL:https://www.masslifesciences.com/event/panel-4-new-pathways-for-a-data-science-workforce-new-pathways-for-a-data-science-workforce%e2%80%8b/
LOCATION:Online\, online
ORGANIZER;CN="Education Development Center":MAILTO:datascience@edc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T140000
DTEND;TZID=America/New_York:20210309T153000
DTSTAMP:20260406T050305
CREATED:20210304T023227Z
LAST-MODIFIED:20210304T023227Z
UID:13487-1615298400-1615303800@www.masslifesciences.com
SUMMARY:Webinar: Incubating and Launching New Life Sciences Companies
DESCRIPTION:This 90-minute webinar will explore the processes\, considerations\, and other factors behind the incubation and launch of new companies by some of today’s leading venture capital firms. We’ll address the following key questions and topics: \nWhat are common sources of ideas for new companies and how do VC business models facilitate and measure the progress and de-risking of translational science?\nHow do venture firms approach financing a new entity and how do they balance capital at risk and value capture with syndication and/or non-dilutive funding from partnerships?\nWhat are venture firms’ views on founder equity for inventors\, for initial key team members\, and for their own firms in their capacity as new company founders?\nWhat are key steps to creating an ideal initial management team? \nWhen \nTuesday\, March 9\, 2021\n2:00 – 3:30 pm ET // 11:00 am – 12:30 pm PT \nThis is an online event.
URL:https://www.masslifesciences.com/event/webinar-incubating-and-launching-new-life-sciences-companies/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T100000
DTEND;TZID=America/New_York:20210309T110000
DTSTAMP:20260406T050305
CREATED:20210222T124122Z
LAST-MODIFIED:20210222T124122Z
UID:13366-1615284000-1615287600@www.masslifesciences.com
SUMMARY:Turbo-charging Neurology Research into Clinical Practice - WEBINAR
DESCRIPTION:Translation of neurology research advances into clinical practice is challenged by the difficulty of compliantly collecting\, calibrating and processing large scale brain image and related data to derive patient insights. \nDuring this webinar\, an esteemed panel of neurology key opinion leaders and innovators will discuss how neurology researchers\, AI-tool developers and innovative technology companies can collaborate to turbo-charge the transfer of brain research into clinical practice.
URL:https://www.masslifesciences.com/event/turbo-charging-neurology-research-into-clinical-practice-webinar/
LOCATION:MA
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210309T093000
DTEND;TZID=Europe/London:20210310T173000
DTSTAMP:20260406T050305
CREATED:20210111T214433Z
LAST-MODIFIED:20210111T214433Z
UID:12926-1615282200-1615397400@www.masslifesciences.com
SUMMARY:3rd Annual Pharma Supply-Chain & Security World 2021 “Supply-Chain\, Drug Serialization and Anti-Counterfeiting” Virtual Conference and Expo
DESCRIPTION:The Annual Pharma Supply Chain and Security World Summit is now online\, and this time with more focus on optimizing your supply chain challenges to ensure an agile\, responsive\, streamlined and secured supply chain in Global platform. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit\, diverted\, and adulterated drugs entering into the supply chain. Apart from having an end to end visibility and traceability within the supply chain\, an effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk\, but also harm the quality of the product\, the integrity of the brand\, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market is estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures. \nBoth industry and governments across the world recognising the importance of implementing product serialization\, it becomes obligatory for all entities within the supply chain to comply with federal or state legislations pertaining to the locations in which they operate \nInitiatives focusing on supply chain monitoring\, such as mass serialisation\, track and trace or hologram tagging\, had mixed outcomes\, as counterfeiters are agile and have found ways to bypass the steps quickly. Pharmaceutical companies and regulators are still developing techniques to stop them by creating intelligence led brand protection strategy. This also reveals numerous gaps in the governmental and industry efforts to safeguard global pharmaceutical and bio-tech supplies. \nCorvus Global Events invites you to Pharma Supply Chain & Security World 2021 – Supply-chain\, Drug Serialization And Anti-Counterfeiting virtual conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas\, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies\, transformation strategies and collaboration methods\, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting. \nIt gives us a great pleasure to welcoming you to the 3rd Annual Pharma Supply Chain & Security World 2021. \nKey Highlights \n• Streamlining your supply chain\n• End to End supply chain\n• Designing an optimal supply chain network\n• Developing a sustainable Serialization strategy\n• Integration of track & trace solutions in production and supply chain\n• Smart Packaging\, Labelling\, Artwork\, Warehouse & Logistics\n• Serialization Data and Analytics driven approach to increase supply chain agility\n• Adoption of Blockchain in pharma supply chain\n• Brand Protection & Securing supply chain integrity\n• Global enterprise level solutions for anti-counterfeiting\n• Tackling pharmaceutical crime – initiatives at multinational\, EU and national level\n• IP and regulatory enforcement\n• Synchrony of the Pharma Industry and professional bodies against counterfeiting\n• Understanding and meeting the needs of DSCSA\, EU FMD and other global regulations\n• Strategies for public awareness and patient protection\n• Best practices to protect your brand\n• The role of the Internet in aiding the counterfeiters – How to overcome the situation?\n• Effective Authentication Technologies\n• Best selection of tamper-evident features\n• Developing a RMP for your supply chain to protect your Brand\, Product and Patient Safety\n• The need to understand and adopt new technologies like IoT\, Analytics\, Blockchain\, Machine Learning and Artificial Intelligence\n• Case study: How companies are structuring their counterfeiting efforts and departments? \nWho should attend the conference? \nAttendees include GMs\, VPs\, Directors\, Heads and Managers of: \n• Pharmaceutical manufacturers and distributors\n• Supply Chain management companies\n• Healthcare professionals\n• Pharmacists\n• Serialization\, Track and Trace solution providers\n• Brand protection\, enforcement\, security\, integrity and management companies\n• Healthcare research organizations\n• Pharmaceutical industry professional associations\n• Anti-counterfeiting organizations\n• Packaging & labelling companies\n• Authentication technology suppliers\n• Contract manufacturing organization (CMO)\n• IT service providers\n• Intellectual Property\, investigators and Trademark council\n• Drug regulatory agencies and customs
URL:https://www.masslifesciences.com/event/3rd-annual-pharma-supply-chain-security-world-2021-supply-chain-drug-serialization-and-anti-counterfeiting-virtual-conference-and-expo/
LOCATION:Online\, online
ORGANIZER;CN="corvus global events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210309
DTEND;VALUE=DATE:20210312
DTSTAMP:20260406T050305
CREATED:20200226T231431Z
LAST-MODIFIED:20200917T134916Z
UID:10689-1615248000-1615507199@www.masslifesciences.com
SUMMARY:Viral Vectors for Gene Therapy- Manufacturing (Virtual)
DESCRIPTION:Course Description \nThis course teaches fundamental concepts in viral vectors for gene therapy and how to manufacture them. The course utilizes case studies and laboratory practices to demonstrate critical steps in the production of viral vectors. \nInstructors \nDr. David McNally (MassBiologics)\, Dr. Phillip Tai (UMass Medical School)\, Dr. Shekar Ganesa (MassBiologics)\, Dr. Sangmook Lee (MassBiologics)\, Tom Larkin (MassBiologics)\, Dr. Gretchen Gee (MassBiologics)\, Dr. Matthew Burak (MassBiologics)\, and more (details to be announced). \nTarget Audience \nScientist\, Senior Research Scientist\, Bioprocess Engineer\, or equivalent in Pharmaceuticals\, Biopharmaceuticals \nObjective \n\nUnderstand the major viral vector systems used for gene therapy and their advantages and disadvantages\nUnderstand the major expression systems used to manufacture viral vectors for use in gene therapy\nUnderstand the biochemistry of viral vectors\, their quality attributes and how to measure them\nDescribe some common pitfalls to avoid when processing viral vectors\nExecute transient transfection processes for the production of AAV using suspension HEK293 cells and process the material generated using filtration and chromatographic methods\n\nModules \n\nIntro to Viral Vectors and their use in gene therapy\nUpstream processing of Viral Vectors\nTour of labs and cGMP facility\nIntroduction/safety – hands on lab based work\nHands on lab work – upstream methods\nDownstream processing of Viral Vectors – Chromatography\nDownstream processing of Viral Vectors – Filtration\nRegulatory Considerations for Gene Therapy Products\nHands on lab work – Downstream Methods\nAnalytical Methods\nAnalytical Case Studies\nHands-on lab work – Analytical Methods\nReview of Analytical Data\n\nRegistration \n\nCost of attendance is $2\,500; 50% discount for academic and government. Please head over to BlueSnapto complete your registration.\n\nContact Information \nFor any question\, please contact bpqc@uml.edu
URL:https://www.masslifesciences.com/event/viral-vectors-for-gene-therapy-manufacturing/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210308T153000
DTEND;TZID=America/New_York:20210329T173000
DTSTAMP:20260406T050305
CREATED:20210203T224921Z
LAST-MODIFIED:20210203T224921Z
UID:13186-1615217400-1617039000@www.masslifesciences.com
SUMMARY:Biotechnology Project Management
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nMassachusetts Companies with 100 Employees or Less: Your employees may be eligible to take the course at no cost through the Small Business Direct Access Program. Please note: Your company’s application to the SBDA Program must be submitted four (4) weeks before your inteded start date of training (the start date of the course). \nTo see if your company is already registered through the Small Business Direct Access Program\, you can check the list of eligible businesses by clicking “List of eligible businesses” on the page here.\nPlease note\, the approval process can take 2-4 weeks. The application does not save progress\, so it is important to have all of the necessary required documents\, referenced in Step 2\, in advance of filling out and submitting your application here. If your company is not listed\, you can register using the form at the bottom of the page\nOnce your company is approved\, the Commonwealth Corporation will notify the contact person by email and you will be added to the List of eligible businesses.\nOnce approved\, please email courses@massbioed.org with the name of the employee(s) who wish to register\, and we will add them to the course roster for the next available course.\nFurther directions on how to enroll employees through the Small Business Direct Access Program can be found here.\nDescription \nThis MassBioEd ten-session online course\, examines critical aspects of project management\, including an overview of the drug development process and regulatory agencies. Participants gain practical experience with project management tools\, such as Product Development Plans\, Responsibility Assignment Matrices\, Communication Plans\, and Work Breakdown Structures. Participants learn to use tools and strategies for working in a team environment to analyze risk\, allocate resources\, track projects\, resolve conflicts\, make decisions\, and manage management and teams. Most importantly\, participants increase their ability to deliver project results. This will be an interactive course with group breakout sessions\, and team activities. We will focus on foundational information\, regulations\, phases I-IV\, and case studies. To encourage engagement\, we will implement gamification of content\, as a teaching technique when discussing specific products or lines of service. \nIn this remote interactive learning environment\, participants gain understanding and skills in the responsibilities\, activities\, and competencies required of a successful Project Manager in the biotechnology industry. Experiential learning labs\, class participation\, and real-world examples are used to maximize educational learning. \n“Biotechnology Project Management” helps executives\, researchers\, technicians\, and managers understand the role of project management and how their job fits into the overall drug development process. \nSchedule: \nMonday\, March 8th\, 2021 at 3:30-6:30 PM\nWednesday\, March 10th\, 2021 at 3:30-5:30 PM\nFriday\, March 12th\, 2021 at 3:30-5:30 PM\nMonday\, March 15th\, 2021 at 3:30-5:30 PM\nWednesday\, March 17th\, 2021 at 3:30-5:30 PM\nFriday\, March 19th\, 2021 at 3:30-5:30 PM\nMonday\, March 22nd\, 2021 at 3:30-5:30 PM\nWednesday\, March 24th\, 2021 at 3:30-5:30 PM\nFriday\, March 26th\, 2021 at 3:30-5:30 PM\nMonday\, March 29th\, 2021 at 3:30-5:30 PM
URL:https://www.masslifesciences.com/event/biotechnology-project-management-2/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210308T090000
DTEND;TZID=America/New_York:20210312T113000
DTSTAMP:20260406T050305
CREATED:20210203T225048Z
LAST-MODIFIED:20210203T225048Z
UID:13184-1615194000-1615548600@www.masslifesciences.com
SUMMARY:Transitioning to Leader\, For New Managers
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nTransitioning to Leader\, For New Managers provides participants with a clear understanding of the leader-manager they aim to be and the essential skills and strategies to help them get there. Approaches to effective communication and how to foster collaboration among teams\, both remotely and in-person are discussed. Participants will also learn the fundamentals for interviewing and hiring\, and more. \nSchedule \nMonday\, March 8th\, 2021 9:00 AM – 11:15 AM\nWednesday\, March 10th\, 2021 9:00 AM – 11:15 AM\nFriday\, March 12th\, 2021 9:00 AM – 11:15 AM\nAgenda \nSession 1:\nTransitioning to Leader-Manager\nSetting Employees Up for Success \nSession 2:\nManaging Employees Remotely \nSession 3:\nShaping Culture\nManager’s Role in Employee Engagement
URL:https://www.masslifesciences.com/event/transitioning-to-leader-for-new-managers-3/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210305T090000
DTEND;TZID=America/New_York:20210305T090000
DTSTAMP:20260406T050305
CREATED:20210304T023919Z
LAST-MODIFIED:20210304T024027Z
UID:13431-1614934800-1614934800@www.masslifesciences.com
SUMMARY:Opportunities and Challenges for Life Science Start-ups
DESCRIPTION:C2I Accelerator\, Entrepreneur forum is pleased to announce its first webinar for 2021 on March 5th\, 2021 at 9.00 am. A Panel Discussion focusing on “OPPORTUNITIES AND CHALLENGES FOR LIFE SCIENCE START-UPS” \nThe panel includes John L. Brooks III Managing Director Healthcare Capital LLC (Moderator); Jill Becker\, Ph.D. CEO\, Kebotix\, Nandan Padukone\, Ph.D. CEO\, IM Therapeutics\, Richard Kertzman\, Managing Director First Republic\, and Chris Garabedian\, CEO\, Xontogeny. \nfor registration please follow the link: https://zoom.us/webinar/register/WN_eUYqtUAaR9KjtzF7Tcfbzw
URL:https://www.masslifesciences.com/event/opportunities-and-challenges-for-life-science-start-ups/
LOCATION:Online\, online
END:VEVENT
END:VCALENDAR